Atomoxetine, a selective norepinephrine reuptake inhibitor, acts by increasing extracellular norepinephrine levels in the brain, which may modulate pain perception and neurovascular signaling in cluster headache. While primarily used as an ADHD medication, it has shown potential in reducing cluster headache frequency and intensity by potentially altering central nervous system neurotransmitter dynamics and pain processing pathways.